Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1

Nature

Volumn 392, Issue 6673, 1998, Pages 296-299

  Zhang, Jianke ^a   Cado, Dragana ^a   Chen, Ann ^a   Kabra, Nisha H ^a   Winoto, Astar ^a  

^a USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; FAS ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; FLOW CYTOMETRY; IMMUNE DEFICIENCY; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; THYMOCYTE;

ANIMALIA; CHIMAERIFORMES;

EID: 0032546387     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/32681     Document Type: Article

References (30)

1. Nagata, S. & Golstein, P. The Fas death factor. Science 267, 1449-1455 (1995).
2. Matiba, B., Mariani, S. M. & Krammer, P. H. The CD95 system and the death of a lymphocyte. Semin. Immunol. 9, 59-68 (1997).
3. Boldin, M. P. et al. A novel protein that interacts with the death domain. J. Biol Chem. 270, 7795-7798 (1995).
4. Chinnaiyan, A. M., O'Rourke, K., Tewari, M. & Dixit, V. M. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81 505-512 (1995).
5. Kischkel, F. C. et al. Cytotoxicity-dependent APO-1 (Fu/CD95) associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J. 14, 5579-5588 (1995).
6. Zhang, J. & Winoto, A. A mouse Fas-associated protein with homology to the human Mort1/FADD protein is essential for Fas-induced apoptosis. Mol. Cell. Biol. 16, 2756-2763 (1996).
7. Muzio, M. et al. PUCE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85, 817-827 (1996).
8. Boldin, M. P., Goncharov, T. M., Goltsev, Y. V. & Wallach, D. Involvement of MACH, a novel MORT1/ FADD-interacting protease, in Fas/APO-1 and TNF receptor-induced cell death. Cell 85, 803-815 (1996).
9. Chinnaiyan, A. M. et al. FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J. Biol. Chem. 271, 4961-4965 (1996).
10. Hsu, H., Shu, H.-B., Pan, M.-G. & Goeddel, D. V. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transaction pathways. Cell 84, 299-308 (1996).
11. Bodmer, J.-L et al. TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95). Immunity 6, 79-88 (1997).
12. Chinnaiyan, A. M. et al. Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science 274, 990-992 (1996).
13. Kitson, J. et al. A death-domain-containing receptor that mediates apoptosis. Nature 384, 372-375 (1996).
14. Marsters, S. A. et al. Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-κB. Curr. Biol 6, 1669-1676 (1996).
15. Yang, X., Khosravi-Far, R., Chang, H. V. & Baltimore, D. Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell 89, 1067-1076 (1997).
16. Chen, J., Lansford, R., Stewart, V., Young, F. & Alt, F. W. RAG-2-deficient blastoyst complementation: An assay of gene function in lymphocyte development. Proc. Natl Acad. Sci. USA 90, 4528-4532 (1993).
17. Mortensen, R. M., Conner, D. A., Chao, S., Geisterfer-Lowrance, A. A. & Seidman, J. G. Production of homozygous mutant ES cells with a single targeting construct. Mol. Cell. Biol. 12, 2391-2395 (1992).
18. Mombaerts, P. et al. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68, 869-877 (1992).
19. Chu, K., Niu, X. & Williams, L. T. A Fas-associated protein factor, FAF1, potentiates Fas-mediated apoptosis. Proc. Natl Acad. Sci. USA 92, 11894-11898 (1995).
20. Sato, T., Irie, S., Kitada, S. & Reed, J. C. FAP-1: a protein tyrosine phosphatase that associates with Fas. Science 268, 411-415 (1995).
21. Stanger, B. Z., Leder, P., Lee,T.-H., Kim, E. & Seed, B. RIP; a novel protein containing a death domain that interacts with Fas/APO-1 (D95) in yeast and causes cell death. Cell 81, 513-523 (1995).
22. Ogasawara, J., Suda, T. & Nagata, S. Selective apoptosis of CD4+CDS8+ thymocytes by the anti-Fas antibody. J. Exp. Med. 181, 485-491 (1995).
23. Hernandez-Caselles, T. & Stutman, O. Immune functions of tumor necrosis factor. J. Immunology 151, 3999-4012 (1993).
24. Suzuki, H. et al. Derugulated T cell activation and autoimmunity in mice lacking intrleukin-2 receptor β. Science 268, 1472-1476 (1995).
25. 1/S transition to acquire susceptibility to Fas-mediated apoptosis. J. Immunol 157, 4309-4315 (1996).
26. Lenardo, M. J. The molecular regulation of lymphocyte apoptosis. Semin. Immunol. 9, 1-5 (1997).
27. Parijs, L. V. et al. Functional responses and apoptosis of CP25 (IL-2Rα)-deficient T cells expressing a transgenic antigen receptor1. J. Immunol 158, 3738-3745 (1997).
28. Lenardo, M. T. Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature 353, 854-861(1991).
29. Ramirez-Solis, R., Davis, A. C. & Bradley, A. Gene targeting in embryonic stem cells. Methods Enzymol. 225, 855-878 (1993).
30. Schmid, I., Uittenbogaart, C. H., Keld, B. & Giorgi, J. V. A rapid method for measuring apoptosis and dual-color immunofluorescence by single User flow cytometry. J. Immunol. Methods 170, 145-157 (1994).